Basic Information
| RNALocate ID: | RLID:11001001 |
| RNA Symbol: | hsa-miR-100-5p |
| Localization: | Microvesicle |
RNA Information
| RNA Name: | hsa-miR-100 |
| RNA ID: | miRBase:MIMAT0000098 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23539611 |
| Tissue/Cell Line: | Seminal plasma |
| Method: | Microarray |
| Description: | In order to assess the reversibility of post-vasectomy miRNA sequelae, we investigated whether SMV miRNAs altered by vasectomy could be retrieved in SMVs from normospermic vasovasostomized donors. miRNA microarray profiling performed on SMVs from normal, vasectomized and vasovasostomized donors identified 313 miRNAs whose intensity was above the threshold of detection. Among these miRNAs, 293 were detected in samples from normal donors, 275 in vasectomized donors and 298 in vasovasostomized donors (Fig. 3, Supplementary data, Table SIV). Data are collected from Table S4. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001431 | Cytoplasm | Neural progenitor cells | 21363885 |
| RLID:01001432 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001433 | Mitochondrion | Cell line (HeLa) | 22984580 |
| RLID:01001434 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001435 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:11000993 | Exosome | Human cervical cancer cell line (HeLa) | 25760330 |
| RLID:11000994 | Exosome | LAC cell line (A549) | 28553110 |
| RLID:11000995 | Exosome | Primary dendritic cells | 21505438 |
| RLID:11000996 | Exosome | Renal cancer cells | 21670082 |
| RLID:11000997 | Exosome | Brain tissue | 23382797 |
| RLID:11000998 | Exosome | Plasma | 23663360 |
| RLID:11000999 | Exosome | Human esophageal cancer cell line (EC9706) | 25184951 |
| RLID:11001000 | Exosome | B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells | 25242326 |
| RLID:11001002 | Microvesicle | Hepatoma cells | 23771658 |
| RLID-D:11000032 | Exosome | Blood|Breast tissue|Colon tissue|Endothelial cells|Epithelial cells|Seminal fluid|Tongue tissue | |
| RLID-D:11000297 | Microvesicle | Blood|Breast cell line|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-100-5p | Diffuse large b cell lymphoma | MNDR-E-MI-02417 |
| MNDR | hsa-miR-100-5p | Mantle cell lymphoma | MNDR-E-MI-02418 |
| MNDR | hsa-miR-100-5p | Splenic marginal zone lymphoma | MNDR-E-MI-02419 |
| MNDR | hsa-miR-100-5p | Colorectal adenoma | MNDR-E-MI-02420 |
| MNDR | hsa-miR-100-5p | Oral squamous cell carcinoma | MNDR-E-MI-02421 |
| MNDR | hsa-miR-100-5p | Large cell neuroendocrine cancer | MNDR-E-MI-02422 |
| MNDR | hsa-miR-100-5p | Medulloblastoma | MNDR-E-MI-02423 |
| MNDR | hsa-miR-100-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-02424 |
| MNDR | hsa-miR-100-5p | Ovarian clear cell carcinoma | MNDR-E-MI-02425 |
| MNDR | hsa-miR-100-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-02426 |
| MNDR | hsa-miR-100-5p | Lymphoma | MNDR-E-MI-02427 |
| MNDR | hsa-miR-100-5p | Lymphoma non-hodgkin | MNDR-E-MI-02428 |
| MNDR | hsa-miR-100-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-02429 |
| MNDR | hsa-miR-100-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-02430 |
| MNDR | hsa-miR-100-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-02431 |
| MNDR | hsa-miR-100-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-02432 |
| MNDR | hsa-miR-100-5p | Her2-receptor positive breast cancer | MNDR-E-MI-02433 |
| MNDR | hsa-miR-100-5p | Breast cancer luminal | MNDR-E-MI-02434 |
| MNDR | hsa-miR-100-5p | Niemann-pick disease type c | MNDR-E-MI-02435 |
| MNDR | hsa-miR-100-5p | Prostate cancer | MNDR-E-MI-02436 |
| MNDR | hsa-miR-100-5p | Gastric cancer | MNDR-E-MI-02437 |
| MNDR | hsa-miR-100-5p | Gastric lymphoma | MNDR-E-MI-02438 |
| MNDR | hsa-miR-100-5p | Alzheimer disease | MNDR-E-MI-02439 |
| MNDR | hsa-miR-100-5p | Intracranial aneurysm | MNDR-E-MI-02440 |
| MNDR | hsa-miR-100-5p | Bladder cancer | MNDR-E-MI-02441 |
| MNDR | hsa-miR-100-5p | Esophageal carcinoma | MNDR-E-MI-02442 |
| MNDR | hsa-miR-100-5p | Dysautonomia familial | MNDR-E-MI-02443 |
| MNDR | hsa-miR-100-5p | Myotonic dystrophy | MNDR-E-MI-02444 |
| MNDR | hsa-miR-100-5p | Head and neck cancer | MNDR-E-MI-02445 |
| MNDR | hsa-miR-100-5p | Ataxia telangiectasia | MNDR-E-MI-02446 |
| MNDR | hsa-miR-100-5p | Huntington disease | MNDR-E-MI-02447 |
| MNDR | hsa-miR-100-5p | Chorea | MNDR-E-MI-02448 |
| MNDR | hsa-miR-100-5p | Cardiovascular disease | MNDR-E-MI-02449 |
| MNDR | hsa-miR-100-5p | Lung cancer | MNDR-E-MI-02450 |
| MNDR | hsa-miR-100-5p | Biliary atresia | MNDR-E-MI-02451 |
| MNDR | hsa-miR-100-5p | Down syndrome | MNDR-E-MI-02452 |
| MNDR | hsa-miR-100-5p | Parkinson disease | MNDR-E-MI-02453 |
| MNDR | hsa-miR-100-5p | Colonic adenomas | MNDR-E-MI-02454 |
| MNDR | hsa-miR-100-5p | Basal-like breast cancer | MNDR-E-MI-02455 |
| MNDR | hsa-miR-100-5p | Pancreatic cancer | MNDR-E-MI-02456 |
| MNDR | hsa-miR-100-5p | Melanoma | MNDR-E-MI-02457 |
| MNDR | hsa-miR-100-5p | Epithelial ovarian cancer | MNDR-E-MI-02458 |
| MNDR | hsa-miR-100-5p | Colon cancer | MNDR-E-MI-02459 |
| MNDR | hsa-miR-100-5p | Relapsing-remitting multiple sclerosis | MNDR-E-MI-02460 |
| MNDR | hsa-miR-100-5p | Ovarian cancer | MNDR-E-MI-02461 |
| MNDR | hsa-miR-100-5p | Prostate adenocarcinoma | MNDR-E-MI-02462 |
| MNDR | hsa-miR-100-5p | Carcinoma ductal breast | MNDR-E-MI-02463 |
| MNDR | hsa-miR-100-5p | Glioblastoma | MNDR-E-MI-02464 |
| MNDR | hsa-miR-100-5p | Astrocytoma | MNDR-E-MI-02465 |
| MNDR | hsa-miR-100-5p | Glioma | MNDR-E-MI-02466 |
| MNDR | hsa-miR-100-5p | Chronic obstructive pulmonary disease | MNDR-E-MI-02467 |
| MNDR | hsa-miR-100-5p | Chordoma | MNDR-E-MI-02468 |
| MNDR | hsa-miR-100-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-02469 |
| MNDR | hsa-miR-100-5p | Temporal lobe epilepsy | MNDR-E-MI-02470 |
| MNDR | hsa-miR-100-5p | Osteosarcoma | MNDR-E-MI-02471 |
| MNDR | hsa-miR-100-5p | Carotid artery thrombosis | MNDR-E-MI-02472 |
| MNDR | hsa-miR-100-5p | Breast carcinoma | MNDR-E-MI-02473 |
| MNDR | hsa-miR-100-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-02474 |
| MNDR | hsa-miR-100-5p | Meningioma | MNDR-E-MI-02475 |
| MNDR | hsa-miR-100-5p | Uterine cancer | MNDR-E-MI-02476 |
| MNDR | hsa-miR-100-5p | Cervical adenocarcinoma | MNDR-E-MI-02477 |
| MNDR | hsa-miR-100-5p | Gastric adenocarcinoma | MNDR-E-MI-02478 |
| MNDR | hsa-miR-100-5p | Cervical squamous cell carcinoma | MNDR-E-MI-02479 |
| MNDR | hsa-miR-100-5p | Pituitary adenoma | MNDR-E-MI-02480 |
| MNDR | hsa-miR-100-5p | Lung squamous cell carcinoma | MNDR-E-MI-02481 |
| MNDR | hsa-miR-100-5p | Non-small cell lung cancer | MNDR-E-MI-02482 |
| MNDR | hsa-miR-100-5p | Lung adenocarcinoma | MNDR-E-MI-02483 |
| MNDR | hsa-miR-100-5p | Adrenocortical carcinoma | MNDR-E-MI-02484 |
| MNDR | hsa-miR-100-5p | Thyroid carcinoma | MNDR-E-MI-02485 |
| MNDR | hsa-miR-100-5p | Ovarian carcinoma | MNDR-E-MI-02486 |
| MNDR | hsa-miR-100-5p | Bladder urothelial carcinoma | MNDR-E-MI-02487 |
| MNDR | hsa-miR-100-5p | Bladder carcinoma | MNDR-E-MI-02488 |
| MNDR | hsa-miR-100-5p | Skin cancer | MNDR-E-MI-02489 |
| MNDR | hsa-miR-100-5p | Intrastent restenosis | MNDR-E-MI-02490 |
| MNDR | hsa-miR-100-5p | Cervical cancer | MNDR-E-MI-02491 |
| MNDR | hsa-miR-100-5p | Carcinoma renal cell | MNDR-E-MI-02492 |
| MNDR | hsa-miR-100-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-02493 |
| MNDR | hsa-miR-100-5p | Renal clear cell carcinoma | MNDR-E-MI-02494 |
| MNDR | hsa-miR-100-5p | Biliary tract cancer | MNDR-E-MI-02495 |
| MNDR | hsa-miR-100-5p | Adenocarcinoma of esophagus | MNDR-E-MI-02496 |
| MNDR | hsa-miR-100-5p | Cholangiocarcinoma | MNDR-E-MI-02497 |
| MNDR | hsa-miR-100-5p | Esophageal cancer | MNDR-E-MI-02498 |
| MNDR | hsa-miR-100-5p | Liver cirrhosis | MNDR-E-MI-02499 |
| MNDR | hsa-miR-100-5p | Lung small cell carcinoma | MNDR-E-MI-02500 |
| MNDR | hsa-miR-100-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-02501 |
| MNDR | hsa-miR-100-5p | Myocardial infarction | MNDR-E-MI-02502 |
| MNDR | hsa-miR-100-5p | Adenoma | MNDR-E-MI-02503 |
| MNDR | hsa-miR-100-5p | Breast invasive carcinoma | MNDR-E-MI-02504 |
| MNDR | hsa-miR-100-5p | Early hepatocellular carcinoma | MNDR-E-MI-02505 |
| MNDR | hsa-miR-100-5p | B-cell lymphoma | MNDR-E-MI-02506 |
| MNDR | hsa-miR-100-5p | Rheumatoid arthritis | MNDR-E-MI-02507 |
| MNDR | hsa-miR-100-5p | T-cell leukemia | MNDR-E-MI-02508 |
| MNDR | hsa-miR-100-5p | Malignant pleural mesothelioma | MNDR-E-MI-02509 |
| MNDR | hsa-miR-100-5p | Neuroblastoma | MNDR-E-MI-02510 |
| MNDR | hsa-miR-100-5p | Barrett's adenocarcinoma | MNDR-E-MI-02511 |
| MNDR | hsa-miR-100-5p | Hodgkin lymphoma | MNDR-E-MI-02512 |
| MNDR | hsa-miR-100-5p | Burkitt lymphoma | MNDR-E-MI-02513 |
| MNDR | hsa-miR-100-5p | Tonsil cancer | MNDR-E-MI-02514 |
| MNDR | hsa-miR-100-5p | Skin cutaneous melanoma | MNDR-E-MI-02515 |
| MNDR | hsa-miR-100-5p | Skin melanoma | MNDR-E-MI-02516 |
| MNDR | hsa-miR-100-5p | Acute myeloid leukemia | MNDR-E-MI-02517 |
| MNDR | hsa-miR-100-5p | Colorectal cancer | MNDR-E-MI-02518 |
| MNDR | hsa-miR-100-5p | Multiple myeloma | MNDR-E-MI-02519 |
| MNDR | hsa-miR-100-5p | Esophageal squamous cell carcinoma | MNDR-E-MI-02520 |
| MNDR | hsa-miR-100-5p | Ependymoma | MNDR-E-MI-02521 |
| MNDR | hsa-miR-100-5p | Nasopharyngeal cancer | MNDR-E-MI-02522 |
| MNDR | hsa-miR-100-5p | Sleep deprivation | MNDR-E-MI-02523 |
| MNDR | hsa-miR-100-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-02524 |
| MNDR | hsa-miR-100-5p | Pancreatitis chronic | MNDR-E-MI-02525 |
| MNDR | hsa-miR-100-5p | Barrett's carcinogenesis | MNDR-E-MI-02526 |
| MNDR | hsa-miR-100-5p | Breast cancer her3+ negative | MNDR-E-MI-02527 |
| MNDR | hsa-miR-100-5p | High grade dysplastic nodule | MNDR-E-MI-02528 |
| MNDR | hsa-miR-100-5p | HPV | MNDR-E-MI-02529 |
| MNDR | hsa-miR-100-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-02530 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ACKR3 | Homo sapiens | RR00034282 |
TOP